Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Capital Expenditures (2016 - 2026)

Nutex Health (NUTX) has disclosed Capital Expenditures for 13 consecutive years, with $1.2 million as the latest value for Q1 2026.

  • For Q1 2026, Capital Expenditures rose 1776.56% year-over-year to $1.2 million; the TTM value through Mar 2026 reached $3.7 million, up 124.04%, while the annual FY2025 figure was $2.5 million, 9.64% up from the prior year.
  • Capital Expenditures hit $1.2 million in Q1 2026 for Nutex Health, down from $1.4 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $8.6 million in Q1 2022 and bottomed at -$7.9 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $1.8 million, with a median of $751000.0 recorded in 2025.
  • Year-over-year, Capital Expenditures plummeted 167.23% in 2022 and then surged 1776.56% in 2026.
  • Nutex Health's Capital Expenditures stood at -$7.9 million in 2022, then skyrocketed by 89.52% to -$825487.0 in 2023, then surged by 147.85% to $395000.0 in 2024, then skyrocketed by 256.71% to $1.4 million in 2025, then decreased by 14.76% to $1.2 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $1.2 million, $1.4 million, and $302000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.